Unmet needs in treating oligometastatic prostate cancer Published 2022-09-09 Download video MP4 360p Recommendations 01:55 Patient response to Pembrolizumab 06:07 The Pros and Cons of Testing PSA Levels for Prostate Cancer 02:45 Initial chemotherapy options for advanced and metastatic NUT carcinoma 05:45 HER2-Positive Breast Cancer: A Paradigm Shift in Diagnosis and Therapy 02:31 Targeting SMARCA4 mutations in lung cancer 10:15 "This Is the Most Powerful Longevity Drug" - Dr. Rhonda Patrick 02:00 Testing for rare mutations in lung cancer in the US 01:41 ADAPT trial: Endocrine + ribociclib vs. chemotherapy in HR+/HER2- early breast cancer 01:56 Impact of MRI and 12-gene expression assay on radiotherapy in DCIS: 5-year findings 00:35 Progress in ctDNA research: advancements in early-stage breast cancer detection 08:06 An introduction to the MAPK signaling pathway and pan-RAF inhibitors 04:07 E4112: MRI and gene expression optimization of local therapy for ductal carcinoma in situ 01:32 DESTINY-Breast15: T-DXd in patients with HR+HR- and HER2-low or HER2 IHC 0 metastatic breast cancer 00:47 Advancing precision medicine: cell-free DNA fragment omics in metastatic HER2-negative breast cancer 02:35 Meta-analysis: axillary surgery impact in breast cancer treatment outcomes 03:25 Characterization and diagnosis of NUT carcinoma 02:08 Racial disparities in lung cancer biomarker testing and clinical trial recruitment 01:24 Advancing personalized breast cancer treatment: insights from ECOG-ACRIN E4112 and ADAPTcycle trials 02:14 Breast cancer prevention: hormonal treatments and emerging strategies Similar videos 00:49 Unmet needs for radiotherapy in metastatic and oligometastatic prostate cancer 17:43 Management of Oligometastatic Prostate Cancer: From Imaging to Therapy 02:05 EXTEND: Combination therapy for oligometastatic prostate cancer 01:43 Defining and classifying oligometastatic prostate cancer 01:46 Dr. Yu Discusses Treatment Strategies for Patients With Oligometastatic Prostate Cancer 03:40 Combination Therapy for Oligometastatic Prostate Cancer | Eugene Kwon, MD & Mark Moyad, MD | PCRI 01:42 Dr. Einstein on Treatment Approaches in Early Oligometastatic Prostate Cancer 01:33 Management of Oligometastatic Prostate Cancer | Jessica Wong, MD | ESMO22 Pennsylvania 11:39 Oligometastatic Disease - 2021 Prostate Cancer Patient Conference 00:31 Unmet needs in the use of circulating tumor cells for prostate cancer 01:22 The unmet needs of patients with oligometastatic disease 00:52 Defining oligometastatic disease, and its impact on treatment in prostate cancer: 2022 ESMO Florida 03:59 Chemotherapy for Oligometastatic Prostate Cancer 01:17 Treatment landscape for metastatic hormone-sensitive prostate cancer 02:40 Oligometastatic prostate cancer and the importance of the radiation oncologist in its management 01:03 Management of Oligometastatic Prostate Cancer | Ravi Madan, MD | ESMO22 Colorado 04:28 High-Risk Mutations in Oligometastatic Prostate Cancer Patients 00:39 Stereotactic body RT in patients with oligometastatic CRPC undergoing 1L treatment with abiraterone More results